On December 6, the National Medical Insurance Administration announced the postponement of the negotiations on the list of National medical insurance drugs for 2022, saying that considering the impact of the COVID-19 pandemic and the needs of the negotiations, the field negotiations on the list of National medical insurance drugs for 2022 will be postponed. After the specific time is determined, the negotiating parties will be informed about one week in advance. The agreement will expire on December 31, 2022 in the list of negotiated drugs, the original agreement will be automatically extended to the new list of formal implementation.
If the adjustment of the medical insurance catalogue is to be given to the people as a New Year's gift, then perhaps the work will be completed by the Spring Festival? That means negotiations on the health care package are drawing near, with Lunar New Year's Eve, which falls on Jan. 21, almost a month away.
The term for the adjustment of the medical insurance catalogue is "completed", while the term for the centralized purchase of dental implant consumables is "steadily advanced". From this point of view, the promotion speed of dental implant collection may lag behind the adjustment of the medical insurance catalogue.
In addition, it is also very clear that the epidemic related drug supplies will usher in a price reduction. The meeting called for all-out efforts to serve the overall situation of epidemic prevention and control, optimize and adjust the epidemic prevention and control policy of medical insurance, continue to reduce the prices of epidemic prevention and control drugs and other consumables, and effectively ensure that people seek medical treatment.
Many local health insurance bureaus have moved quickly under the new epidemic control regime. Recently, the Beijing Municipal Bureau of Medical Insurance issued a notice to temporarily include 6 types of drugs -- compound amphenolamine capsules, compound amphenolacetaminophen oral liquid, pediatric amphenolHuangnamin granules, amphenolHuangmin capsules, Clofenhuangmin tablets, and ambroterol oral solution into the medical insurance list. The reimbursement ratio is Class A drugs. The temporary inclusion deadline is March 18, 2023.
In addition, in order to ensure the supply of anti-epidemic drugs, a number of provinces have also issued a notice to urgently hang anti-epidemic drugs.
The medical insurance Bureau of Hunan Province issued a notice today to launch the green channel for the emergency hanging of urgently needed drugs in clinical diagnosis and treatment of the novel coronavirus outbreak. The provincial Public resources trading Center shall inform the manufacturing enterprises to apply for online listing of the drugs in the drug consumables recruitment and purchasing subsystem of Hunan medical insurance Information Platform, which shall be included in the emergency online listing catalogue, and the purchasing authority of primary medical institutions shall be opened.
On the same day, Sichuan Provincial Medical Insurance Bureau also issued a document to temporarily put on the Internet the recommended drugs for prevention and control of COVID-19 and recommended drugs for home treatment formulated by the state and Sichuan. Sichuan not only opened a green channel for the Internet, but also gave preferential policies, including that the purchase amount was not included in the monitoring scope of the amount of drugs purchased for the record of clinical urgent need in public medical institutions throughout the year; The rule that only drugs that have been reviewed by three companies will be allowed to be listed on the Internet, regardless of whether they have been reviewed or not. In addition, for other drugs that are not on the Internet but belong to epidemic prevention and control drugs, hospitals can purchase them offline and put them on record within 30 days.
The Medical Insurance Bureau of Zhejiang Province also recently agreed to the request of Zhejiang Health Commission to temporarily put antipyretics and analgesic products on the Internet. Ibuprofen granules of Zhejiang Kangenbei Pharmaceutical Co., LTD., and children's acetaminophen Huangnamin granules of Zhejiang Yafeng Pharmaceutical Factory Co., LTD. And Wambond Pharmaceutical Group Co., LTD., were included in the temporary shortage drug purchase catalog for hospitals to purchase.
In addition to the drugs recommended by the National Health Commission for epidemic prevention and control, Shanghai has also included all OTC compound preparations for relieving cold symptoms in its medical insurance catalogue into the green channel.
However, the preferential policies of these epidemic drugs are also limited. For example, Shanghai has stipulated a period of validity of 3 months, and Shanghai requires enterprises to promise to supply at the lowest purchase price of 15 provinces and cities, and to specify the supply and arrival date. The procurement cycle of online suspension is tentatively set at 3 months. After the epidemic situation is stabilized, the above-mentioned online suspension drugs will be dynamically adjusted. Drugs that meet the municipal regulations on online suspension and price negotiation will be included in the scope of the municipal regular drug suspension network, and those that do not meet the requirements will be withdrawn from the Internet.
The Hunan provincial Medical Insurance Bureau also said that after the epidemic prevention and control work, the emergency drugs will be adjusted. At the same time, it also vowed to cooperate with market supervision and other departments, strictly crack down on the use of the epidemic peak of drug prices, high offline trading, illegal disguised markups, commercial bribery and other behaviors.
Sichuan Medical Equipment Purchasing Center said that it will cooperate with the medical security department to strengthen the monitoring of related drug prices, maintain the linkage with the market supervision department of price supervision, and take letter consultation, interview or credit evaluation as appropriate to restrain unreasonable price increases.
